New England Biolabs (United States)

New England Biolabs (United States)

New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

76%


Total
Publications

1.7K


Total Open
Publications

1.3K


Total
Citations

83K


Open Access
Percentage

76%


Total
Publications

1.7K


Total Open
Publications

1.3K


Total
Citations

83K

Wikipedia

Website

download

Breakdown

9% 47% 20% 24%

Publisher Open

9%

Both

47%

Other Platform Open

20%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

50%OA Journal

OA Journal 50%

484

Hybrid 30%

286

No Guarantees 20%

192

Other Platform Open

Domain 87%

1K

Institution 21%

238

Public 17%

199

Preprint 12%

142

Other Internet 11%

126

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
999
Europe PMC
Domain
831
Semantic Scholar
Public
184
bioRxiv
Preprint
113
DOI
Other Internet
52
Harvard University - Digital Access to Scholarship at Harvard (DASH)
Institution
47
Research Square
Preprint
30
Unknown Repository
Other Internet
26
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
26
Figshare
Public
24
1 / 14

Data updated 13 May 2024

Share

Share

Share